Fig. 1: ERBB2 mutational profile in newly diagnosed NSCLC patients. | npj Precision Oncology

Fig. 1: ERBB2 mutational profile in newly diagnosed NSCLC patients.

From: Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients

Fig. 1

ERBB2 oncogenic mutations and proportion reported by OncoKB and COSMIC in Geneplus (a, c) and Guardant360 (b, d). e Proportion of ERBB2 oncogenic mutations for 70 patients with co-occurring ERBB2 amplification in Geneplus cohort. f ERBB2 mutational profile of the 70 patients with co-occurring ERBB2 amplification in Geneplus cohort.

Back to article page